A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
Phase 1
- Conditions
- HER-2 Positive Colorectal Cancer
- Interventions
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Qingdao Zhixin Health Technology Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT04227041
- Locations
- 🇨🇳
Qingdao University Hospital, Qingdao, Shandong, China
The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus
Not Applicable
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: conventional treatmentOther: Maltose app
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Qingdao Zhixin Health Technology Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT03061851
- Locations
- 🇨🇳
Qingdao University Hospital, Qingdao, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath